expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
Published 1 year ago • 1.3K plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
21:47
esmo daily reporter talk: the role of cdk4/6 inhibitors in the early stage of #breastcancer.
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
0:50
investigating mechanisms of resistance to cdk4/6 inhibitors
-
5:45
#esmo21 expert video report on targeting in her2-positive metastatic breast and lung cancers
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
1:07
sequencing first-line cdk4/6 inhibitors in metastatic breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
6:15
breast cancer at esmo 2020: cdk4/6 inhibitors and checkpoint inhibitors
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast